Mechanisms of disease: Is osteoporosis the obesity of bone?

Nature Clinical Practice Rheumatology

Volumn 2, Issue 1, 2006, Pages 35-43

  Rosen, Clifford J ^a,b   Bouxsein, Mary L ^c  

^a JACKSON LABORATORY   (United States)

^b ST JOSEPH HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Adipocyte; Bone; Fat; Obesity; Osteoporosis

Indexed keywords

BETA ADRENERGIC RECEPTOR; CYTOKINE; FATTY ACID DERIVATIVE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; OSTEOCLAST DIFFERENTIATION FACTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; ROSIGLITAZONE;

ADIPOCYTE; AGE DISTRIBUTION; AGING; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE MARROW CELL; BONE MASS; CLINICAL FEATURE; CLINICAL OBSERVATION; ETHNOLOGY; GENETIC PREDISPOSITION; HUMAN; IMMOBILIZATION; MESENCHYMAL STEM CELL; MOLECULAR BIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SECONDARY OSTEOPOROSIS; SEX DIFFERENCE; STEM CELL;

ADIPOCYTES; ADIPOSE TISSUE; AGING; ANIMALS; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; BONE MARROW; CELL DIFFERENTIATION; HUMANS; LEPTIN; MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOPOROSIS; PPAR GAMMA;

EID: 31544457103     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0070     Document Type: Review

References (57)

1. US Department of Health and Human Services (2004) Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville: US Department of Health and Human Services
2. Rosen CJ et al. (2001) Defining the genetics of osteoporosis: Using the mouse to understand man. Osteoporos Int 12: 803-810
3. Recker RR and Heaney RP (1993) Peak bone mineral density in young women. JAMA 270: 2926-2927
4. Goulding A et al. (2001) Bone mineral density and body composition in boys with distal forearm fractures: A dual-energy X-ray absorptiometry study. J Pediatr 139: 509-515
5. Brown S and Rosen CJ (2003) Osteoporosis. Med Clin North Am 87: 1039-1063
6. Kveiborg M et al. (2000) Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions. Exp Gerontol 35: 1061-1074
7. Manolagas SC (2000) Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 21: 115-137
8. Horowitz MC and Lorenzo JA (2004) The origins of osteoclasts. Curr Opin Rheumatol 16: 464-468
9. Gimble JM et al. (1996) The function of adipocytes in the bone marrow stroma: An update. Bone 19: 421-428
10. Cohen PG (2001) Aromatase, adiposity, aging and disease. The hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 56: 702-708
11. Aubin JE (1998) Bone stem cells. J Cell Biochem Suppl 30-31: 73-82
12. Ducy P et al. (2000) Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass. Cell 100: 197-207
13. Takeda S et al. (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317
14. Elefteriou F et al. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434: 514-520
15. Steppan CM et al. (2000) Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 92: 73-78
16. Cornish J et al. (2002) Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol 175: 405-415
17. Burguera B. et al. (2001) Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology 142: 3546-3553
18. Reid IR (2004) Leptin deficiency - lessons in regional differences in the regulation of bone mass. Bone 34: 369-371
19. Hamrick MW et al. (2004) Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34: 376-383
20. Dhillon H et al. (2004) β-adrenergic receptor KO mice have increased bone mass and strength but are not protected from ovariectomy-induced bone loss [abstract]. J Bone Miner Res 19 (Suppl): S32
21. Pierroz DD et al. (2004) β1β2 adrenergic receptor KO mice have decreased total body and cortical bone mass despite increased trabecular number [abstract]. J Bone Miner Res 19 (Suppl): S32
22. Akune T et al. (2004) PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113: 846-855
23. Rzonca SO et al. (2004) Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 145: 401-406
24. Moerman EJ et al. (2004) Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: The role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways. Aging Cell 3: 379-389
25. Uchiyama Y et al. (1994) Adipose conversion is accelerated in bone marrow cells of congenitally osteoporotic SAMP6 mice [abstract]. J Bone Miner Res 9 (Suppl 1): S321
26. Botolin S. et al. (2005) Increased bone adiposity and peroxisomal proliferator-activated receptor-γ2 expression in type I diabetic mice. Endocrinology 146: 3622-3631
27. Rosen CJ et al. (2004) Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program. Bone 35: 1046-1058
28. Rosen CJ et al. (2005) Allelic differences in a quantitative trait locus affecting insulin-like growth factor-I impact skeletal acquisition and body composition. Pediatr Nephrol 20: 255-260
29. Reid IR (2002) Relationships among body mass, its components, and bone. Bone 31: 547-555
30. Wang MC et al. (2005) The relative contributions of lean tissue mass and fat mass to bone density in young women. Bone 37: 474-481
31. von Mach MA et al. (2004) Changes in bone mineral content after surgical treatment of morbid obesity. Metabolism 53: 918-921
32. Cummings SR et al. (1995) Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 332: 767-773
33. Nguyen ND et al. (online 23 February 2005) Abdominal fat and hip fracture risk in the elderly: The Dubbo Osteoporosis Epidemiology Study. [http://www.biomedcentral.com/1471-2474/6/11] (accessed 4 October 2005)
34. Garnero P et al. (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 15: 1526-1536
35. Adler RA and Rosen CJ (1994) Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 23: 641-654
36. Hsu Y et al. (2004) Major determinants of bone mineral density (BMD) at multiple skeletal sites in Chinese [abstract]. J Bone Miner Res 19 (Suppl): S421
37. Wehrli FW et al. (2000) Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology 217: 527-538
38. Meunier P et al. (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80: 147-154
39. Rozman C et al. (1989) Age-related variations of fat tissue fraction in normal human bone marrow depend both on size and number of adipocytes: A stereological study. Exp Hematol 17: 34-37
40. Justesen J. et al. (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2: 165-171
41. Verma S et al. (2002) Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol 55: 693-698
42. Schellinger D et al. (2001) Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR Am J Neuroradiol 22: 1620-1627
43. Yeung DK et al. (2005) Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: A proton MR spectroscopy study. J Magn Reson Imaging 22: 279-285
44. Tuominen JT et al. (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 22: 1196-1200
45. Li X et al. (2005) Steroid effects on osteogenesis through mesenchymal cell gene expression. Osteoporos Int 16: 101-108
46. Cui Q et al. (2000) Pluripotential marrow cells produce adipocytes when transplanted into steroid-treated mice. Connect Tissue Res 41: 45-56
47. van Staa TP et al. (2002) The epidemiology of corticosteroid-induced osteoporosis: A meta-analysis. Osteoporos Int 13: 777-787
48. Ahdjoudj S et al. (2002) Transforming growth factor β2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma. J Bone Miner Res 17: 668-677
49. Papakitsou EF et al. (2004) Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women. Maturitas 47: 185-193
50. Sekiya I et al. (2004) Adipogenic differentiation of human adult stem cells from bone marrow stroma (MSCs). J Bone Miner Res 19: 256-264
51. Rodriguez JP et al. (2000) Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem 79: 557-565
52. Weisberg SP et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808
53. Martin RB and Zissimos SL (1991) Relationships between marrow fat and bone turnover in ovariectomized and intact rats. Bone 12: 123-131
54. Nuttall ME and Gimble JM (2004) Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications. Curr Opin Pharmacol 4: 290-294
55. Lecka-Czernik B et al. (1999) Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2. J Cell Biochem 74: 357-371
56. Dorheim MA et al. (1993) Osteoblastic gene expression during adipogenesis in hematopoietic supporting murine bone marrow stromal cells. J Cell Physiol 154: 317-328
57. Beresford JN et al. (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102: 341-351